Research ArticleBrief Communication
Open Access

A descriptive analysis of gastric cancer with an immunohistochemical Study of Ki67 and p53 as prognostic factors.

Bahrain experience

Mohmmed Awadh, Aysha Darwish, Huda Alqatari, Fatema M. Buzaid and Abdulla Darwish
Saudi Medical Journal December 2023, 44 (12) 1300-1309; DOI: https://doi.org/10.15537/smj.2023.44.12.20230246

References

  1. 1.↵
    1. Morgan E,
    2. Arnold M,
    3. Camargo MC,
    4. Gini A,
    5. Kunzmann AT,
    6. Matsuda T, et al.
    The current and future incidence and mortality of gastric cancer in 185 countries, 2020–40: A population-based modelling study. EClinicalMedicine 2022; 47: 101404
    OpenUrl
  2. 2.↵
    1. Omran BA,
    2. Ansari N.
    Gastric cancer in Bahrain: A retrospective study of histologically confirmed tumours between 2001 and 2007 from the two main Bahraini referral hospitals. Open J Pathol 2015; 05: 129-136.
    OpenUrl
  3. 3.↵
    1. Hu B,
    2. El Hajj N,
    3. Sittler S,
    4. Lammert N,
    5. Barnes R,
    6. Meloni-Ehrig A.
    Gastric cancer: Classification, histology and application of molecular pathology. J Gastrointest Oncol 2012; 3: 251-261.
    OpenUrlCrossRefPubMed
  4. 4.↵
    1. Bray F,
    2. Ferlay J,
    3. Soerjomataram I,
    4. Siegel RL,
    5. Torre LA,
    6. Jemal A.
    Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 2018; 68: 394-424.
    OpenUrlCrossRefPubMed
  5. 5.↵
    1. Torre LA,
    2. Bray F,
    3. Siegel RL,
    4. Ferlay J,
    5. Lortet-Tieulent J,
    6. Jemal A.
    Global cancer statistics, 2012: Global cancer statistics, 2012. CA Cancer J Clin 2015; 65: 87–108.
    OpenUrlCrossRefPubMed
  6. 6.↵
    1. Wang W,
    2. Sun Z,
    3. Deng J-Y,
    4. Qi X-L,
    5. Feng X-Y,
    6. Fang C, et al.
    A novel nomogram individually predicting disease-specific survival after D2 gastrectomy for advanced gastric cancer. Cancer Commun (Lond) 2018; 38: 23.
    OpenUrl
  7. 7.↵
    1. Eman J,
    2. Manal M.
    10 years 2009-2018 Cancer Incidence and Mortality in Kingdom of Bahrain Statistic and Trends by Ministry of Health, Bahrain. page 21-24.
  8. 8.↵
    1. Buckland G,
    2. Travier N,
    3. Huerta JM,
    4. Bueno-de-Mesquita HB,
    5. Siersema PD,
    6. Skeie G, et al.
    Healthy lifestyle index and risk of gastric adenocarcinoma in the epic cohort study. Int J Cancer 2015; 137: 598-606.
    OpenUrlCrossRefPubMed
  9. 9.
    1. Lin SH,
    2. Li YH,
    3. Leung K,
    4. Huang CY,
    5. Wang XR.
    Salt processed food and gastric cancer in a Chinese population. Asian Pac J Cancer Prev 2014; 15: 5293-5298.
    OpenUrlCrossRefPubMed
  10. 10.
    1. Massarrat S,
    2. Stolte M.
    Development of gastric cancer and its prevention. Arch Iran Med 2014; 17: 514-520.
    OpenUrl
  11. 11.↵
    1. Wang F-H,
    2. Zhang X-T,
    3. Li Y-F,
    4. Tang L,
    5. Qu X-J,
    6. Ying J-E, et al.
    The Chinese Society of Clinical Oncology (CSCO): Clinical guidelines for the diagnosis and treatment of gastric cancer, 2021. Cancer Commun (Lond) 2021; 41: 747-795.
    OpenUrl
  12. 12.↵
    1. Sitarz R,
    2. Kocemba K,
    3. Maciejewski R,
    4. Polkowski WP.
    Effective cancer treatment by multidisciplinary teams. Pol Przegl Chir 2012; 84: 371-376.
    OpenUrlPubMed
  13. 13.↵
    1. Liu B,
    2. Li X,
    3. Sun F,
    4. Tong X,
    5. Bai Y,
    6. Jin K, et al.
    HP-CagA+ regulates the expression of CDK4/CyclinD1 via reg3 to change cell cycle and promote cell proliferation. Int J Mol Sci 2019; 21: 224.
    OpenUrl
  14. 14.↵
    1. Chichirau BE,
    2. Diechler S,
    3. Posselt G,
    4. Wessler S.
    Tyrosine Kinases in Helicobacter pylori Infections and gastric cancer. Toxins (Basel) 2019; 11: 591.
    OpenUrl
  15. 15.↵
    1. Nobili S,
    2. Bruno L,
    3. Landini I,
    4. Napoli C,
    5. Bechi P,
    6. Tonelli F, et al.
    Genomic and genetic alterations influence the progression of gastric cancer. World J Gastroenterol 2011; 17: 290-299.
    OpenUrlCrossRefPubMed
  16. 16.
    1. Nikzaban M,
    2. Hakhamaneshi MS,
    3. Fakhari S,
    4. Sheikhesmaili F,
    5. Roshani D,
    6. Ahsan B, et al.
    The chemokine receptor CXCR4 is associated with the staging of gastric cancer. Adv Biomed Res 2014; 3: 16.
    OpenUrl
  17. 17.↵
    1. Hamashima C,
    2. Shibuya D,
    3. Yamazaki H,
    4. Inoue K,
    5. Fukao A,
    6. Saito H, et al.
    The Japanese guidelines for gastric cancer screening. Jpn J Clin Oncol 2008; 38: 259-267.
    OpenUrlCrossRefPubMedWeb of Science
  18. 18.↵
    1. Wei Z,
    2. Huang L,
    3. Zhang X,
    4. Xu A.
    Expression and significance of Her2 and Ki-67 in gastric adenocarcinoma without distant metastasis: a cohort study. BMC Gastroenterol 2020; 20: 343.
    OpenUrl
  19. 19.↵
    1. Busuttil RA,
    2. Zapparoli GV,
    3. Haupt S,
    4. Fennell C,
    5. Wong SQ,
    6. Pang J-MB, et al.
    Role of p53 in the progression of gastric cancer. Oncotarget 2014; 5: 12016-12026.
    OpenUrlCrossRef
  20. 20.↵
    1. Buti L,
    2. Ruiz-Puig C,
    3. Sangberg D,
    4. Leissing TM,
    5. Brewer RC,
    6. Owen RP, et al.
    CagA-ASPP2 complex mediates loss of cell polarity and favors H. pylori colonization of human gastric organoids. Proc Natl Acad Sci U S A 2020; 117: 2645-2655.
    OpenUrlAbstract/FREE Full Text
  21. 21.↵
    1. Pernot S,
    2. Voron T,
    3. Perkins G,
    4. Lagorce-Pages C,
    5. Berger A,
    6. Taieb J.
    Signet-ring cell carcinoma of the stomach: Impact on prognosis and specific therapeutic challenge. World J Gastroenterol 2015; 21: 11428-11438.
    OpenUrlCrossRef
  22. 22.↵
    1. Rota M,
    2. Alicandro G,
    3. Pelucchi C,
    4. Bonzi R,
    5. Bertuccio P,
    6. Hu J, et al.
    Education and gastric cancer risk-An individual participant data meta-analysis in the StoP project consortium. Int J Cancer 2020; 146: 671-681.
    OpenUrlCrossRef
  23. 23.↵
    1. Jemal A,
    2. Bray F,
    3. Center MM,
    4. Ferlay J,
    5. Ward E,
    6. Forman D.
    Global cancer statistics. CA Cancer J Clin 2011; 61: 69-90.
    OpenUrlCrossRefPubMedWeb of Science
  24. 24.↵
    1. Lyons K,
    2. Le LC,
    3. Pham YT-H,
    4. Borron C,
    5. Park JY,
    6. Tran CTD, et al.
    Gastric cancer: epidemiology, biology, and prevention: a mini review. Eur J Cancer Prev 2019; 28: 397-412.
    OpenUrlCrossRefPubMed
  25. 25.↵
    1. Sitarz R,
    2. Skierucha M,
    3. Mielko J,
    4. Offerhaus J,
    5. Maciejewski R,
    6. Polkowski W.
    Gastric cancer: epidemiology, prevention, classification, and treatment. Cancer Manag Res 2018; 10: 239-248.
    OpenUrlCrossRefPubMed
  26. 26.
    1. Banks M,
    2. Graham D,
    3. Jansen M,
    4. Gotoda T,
    5. Coda S,
    6. di Pietro M, et al.
    British Society of Gastroenterology guidelines on the diagnosis and management of patients at risk of gastric adenocarcinoma. Gut 2019; 68: 1545-1575.
    OpenUrlAbstract/FREE Full Text
  27. 27.
    1. Leja M,
    2. Grinberga-Derica I,
    3. Bilgilier C,
    4. Steininger C.
    Review: Epidemiology of Helicobacter pylori infection. Helicobacter 2019; 24: e12635.
    OpenUrl
  28. 28.↵
    1. Yusefi AR,
    2. Bagheri Lankarani K,
    3. Bastani P,
    4. Radinmanesh M,
    5. Kavosi Z.
    Risk factors for gastric cancer: A systematic review. Asian Pac J Cancer Prev 2018; 19: 591-603.
    OpenUrlPubMed
  29. 29.↵
    1. Ahadi M,
    2. Moradi A,
    3. Musavinejad L,
    4. Movafagh A,
    5. Moradi A.
    The expression of p53, CD44, Ki-67, and HER-2/neu markers in gastric cancer and its association with histopathological indicators: A retrospective study. Asian Pac J Cancer Prev 2020; 21: 1607-1614.
    OpenUrl
  30. 30.
    1. Li N,
    2. Deng W,
    3. Ma J,
    4. Wei B,
    5. Guo K,
    6. Shen W, et al.
    Prognostic evaluation of Nanog, Oct4, Sox2, PCNA, Ki67 and E-cadherin expression in gastric cancer. Med Oncol 2015; 32: 433.
    OpenUrl
  31. 31.↵
    1. Huang G,
    2. Chen S,
    3. Wang D,
    4. Wang R,
    5. Lin L,
    6. Chen S, et al.
    High Ki67 expression has prognostic value in surgically-resected T3 gastric adenocarcinoma. Clin Lab 2016; 62: 141-153.
    OpenUrl
  32. 32.↵
    1. Jovanovic I,
    2. Todorovic V N,
    3. Milosavljevic T,
    4. Micev M,
    5. Pesko P,
    6. Bjelovic M, et al.
    Expression of p53 protein in Barrett’s adenocarcinoma and adenocarcinoma of the gastric cardia and antrum. Vojnosanit Pregl 2005; 62: 879-885.
    OpenUrlPubMed
  33. 33.↵
    1. Al-Moundhri MS,
    2. Nirmala V,
    3. Al-Hadabi I,
    4. Al-Mawaly K,
    5. Burney I,
    6. Al-Nabhani M, et al.
    The prognostic significance of p53, p27 kip1, p21 waf1, HER-2/neu, and Ki67 proteins expression in gastric cancer: a clinicopathological and immunohistochemical study of 121 Arab patients. J Surg Oncol 2005; 91: 243-252.
    OpenUrlPubMed
  34. 34.↵
    1. Sanaat Z,
    2. Halimi M,
    3. Ghojezadeh M,
    4. Pirovi AH,
    5. Gharamaleki JV,
    6. Ziae AEJE, et al.
    Immunohistochemical analysis of p53, ki-67, CD44, HER-2/neu expression patterns in gastric cancer, and their association with one year survival in north-west of Iran. Int J Hematol Oncol Stem Cell Res 2013; 7: 15-20.
    OpenUrl
  35. 35.↵
    1. Wu H-H,
    2. Lin W-C,
    3. Tsai K-W.
    Advances in molecular biomarkers for gastric cancer: miRNAs as emerging novel cancer markers. Expert Rev Mol Med 2014; 16: e1.
Back to top

In this issue

Print
Download PDF
Email Article
Citation Tools
Bookmark this article

Jump to section

Keywords